EGFR and chronic obstructive pulmonary disease: Herein, we evaluated the efficacy of ECC-BYF III and ER in inhibiting AMH in a rat model of COPD and evaluated the mechanisms underlying these effects with a particular focus on the EGFR/MAPK signaling pathway.